Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > IF YOU HADN'T HEARD, ISA WILL BE AURINIA...
View:
Post by ISAloser247 on Feb 05, 2013 4:57pm

IF YOU HADN'T HEARD, ISA WILL BE AURINIA...

A MERGER !  A TRIPARTITE AGREEMENT ! ( one of those did a HECK of alot of good in the world during the '30s/'40s of the last century )  Dr. Bundy and his management team , pull another bit of SHHHITE out of their fudge holes !  ISA EXCHANGES ITS" SHARES , FOR SOME PRIVATE VIFOR OFF-SHOOT , AL REMAINS CEO, THE FOCUS IS NEPHRITIS !  SO MUCH FOR TRANSPLANTATION TRIALS !     NO MENTION OF 3SBio, where they are in this configuration !  ISA still needs 3 million financing ,  ILJIN obviously , has had enough licking bullhungs !    .........couldn't pull off the 20 year anniversary thing ,    STILL A FU****** JOKE!  A DESPERATE OLD MAN ,  PAST HIS PRIME ,  GRASPING  WITH SLIEMMEE , SLEEIZZZEE , CRRRAPSTAINED HANDS !
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities